Eucalyptus globulus leaf essential oil
Respiratory Insufficiency
Nilgün ErdoğanmixtureN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Respiratory Insufficiency cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE Northwestern University | Phase 4 | BB |
Rivaroxaban Janssen Research & Development, LLC | Phase 3 | BB |
HYDROMORPHON Northwestern University | Phase 4 | B |
Same molecule, other indications
Eucalyptus globulus leaf essential oil is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →